Clinuvel Pharmaceuticals (UR9.F) Q3 2024 Earnings

Aug 28Confirmed
Q1 2023
Q3 2023
Q1 2024
Q3 2024
0.13
0.18
0.24
0.3

Details

Expected EPS
0.2639687824818
Actual EPS
0.295994957544
Surprise EPS
0.03
Surprise Percent
+12.13%

Description

⁨Clinuvel Pharmaceuticals⁩ (⁦UR9.F⁩) has reported earnings of ⁦0.295994957544⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts